Canopy Growth Corp (NYSE:CGC) technical alert

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Yesterday’s selloff caught a few folks off guard. Its broad base didn’t really spare anyone, except for cannabis stocks. One, in particular, that needs immediate attention.

I’ve been a fan of this sector for a while. In particular, I like Canopy Growth (NYSE:CGC). The hourly chart looks really good here.

CGC Hourly Chart

I highlighted the current consolidation area. Price jumped higher a few days ago and has been sliding sideways. While it did break below the lows for a little bit, it recovered yesterday. When the rest of the market was rolling over, this stock made another move higher and then a sideways consolidation. Here is what I’m looking at zoomed in a little closer.

CGC Hourly Chart

With the entire sector running pretty hot, this stock looks like it wants to take out the recent highs of $23.90. The stop would be at a close below the recent lows.